Crl 预测与赔率· 147 个市场

F
FDA approves Retatrutide this year?

FDA approves Retatrutide this year?

$544k 交易量
$4k 流动性
4
9 个月后结束

24%

Yes

L
LoL: LOS vs Leviatan Esports (BO3) - CBLOL Regular Season

Esports · league of legends

LoL: LOS vs Leviatan Esports (BO3) - CBLOL Regular Season

$0 交易量
$819 流动性
6 天后结束

74%

LOS

C
Counter-Strike: ShindeN vs Charrados FC (BO3) - ESL Challenger League South America Cup #3 Playoffs

Esports · counter strike 2

Counter-Strike: ShindeN vs Charrados FC (BO3) - ESL Challenger League South America Cup #3 Playoffs

$114 交易量
$757 流动性
3 天后结束

92%

ShindeN

W
Will Charles River Laboratories International (CRL) beat quarterly earnings?

Will Charles River Laboratories International (CRL) beat quarterly earnings?

$8k 交易量
$0 流动性
已结束

Yes

W
Will Charles River Laboratories (CRL) beat quarterly earnings?

Will Charles River Laboratories (CRL) beat quarterly earnings?

$15k 交易量
$0 流动性
已结束

Yes

F
FDA approves Dordaviprone?

FDA approves Dordaviprone?

$14k 交易量
$0 流动性
12
已结束

Yes

F
FDA approves UX111?

FDA approves UX111?

$41k 交易量
$0 流动性
12
已结束

No

F
FDA approves EYLEA HD?

FDA approves EYLEA HD?

$6k 交易量
$0 流动性
12
已结束

No

F
FDA approves Donidalorsen?

FDA approves Donidalorsen?

$4k 交易量
$0 流动性
12
已结束

Yes

F
FDA approves FILSPARI REMS modification?

FDA approves FILSPARI REMS modification?

$1k 交易量
$0 流动性
12
已结束

Yes

F
FDA approves Leqembi auto-injection for early Alzheimer’s?

FDA approves Leqembi auto-injection for early Alzheimer’s?

$2k 交易量
$0 流动性
12
已结束

Yes

F
FDA approves Telix Pharmaceuticals’ TLX250-CDx for kidney cancer imaging?

FDA approves Telix Pharmaceuticals’ TLX250-CDx for kidney cancer imaging?

$3k 交易量
$0 流动性
12
已结束

No

F
FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?

FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?

$15k 交易量
$0 流动性
12
已结束

Yes

F
FDA approves Outlook Therapeutics’ ONS-5010 for wet AMD?

FDA approves Outlook Therapeutics’ ONS-5010 for wet AMD?

$4k 交易量
$0 流动性
4
已结束

No

F
FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?

FDA approves Sanofi’s Rilzabrutinib for immune thrombocytopenia?

$3k 交易量
$0 流动性
12
已结束

Yes

F
FDA approves Capricor Therapeutics’ Deramiocel for Duchenne muscular dystrophy by August 31?

FDA approves Capricor Therapeutics’ Deramiocel for Duchenne muscular dystrophy by August 31?

$11k 交易量
$0 流动性
12
已结束

No

F
FDA approves PTC Therapeutics’ Vatiquinone for Friedreich’s ataxia?

FDA approves PTC Therapeutics’ Vatiquinone for Friedreich’s ataxia?

$2k 交易量
$0 流动性
12
已结束

No

F
FDA approves Tonix Pharmaceuticals’ TNX-102 SL for fibromyalgia?

FDA approves Tonix Pharmaceuticals’ TNX-102 SL for fibromyalgia?

$916 交易量
$0 流动性
12
已结束

Yes

F
FDA approves Insmed’s Brensocatib for bronchiectasis?

FDA approves Insmed’s Brensocatib for bronchiectasis?

$2k 交易量
$0 流动性
12
已结束

Yes

F
FDA approves PharmaTher Holdings’ Ketamine?

FDA approves PharmaTher Holdings’ Ketamine?

$7k 交易量
$0 流动性
12
已结束

Yes